PARP4
Protein mono-ADP-ribosyltransferase PARP4
Also known as: ADPRTL1, ARTD4, p193, PARP4_HUMAN, VAULT3, VPARP, VWA5C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKK3
- Gene
- PARP4
- Ensembl
- ENSG00000102699
- Chromosome
- 13
- Canonical length
- 1724 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes poly(ADP-ribosyl)transferase-like 1 protein, which is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. Since this protein is not capable of binding DNA directly, its transferase activity may be activated by other factors such as protein-protein interaction mediated by the extensive carboxyl terminus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1724 residues, UniProt reviewed canonical sequence.
>Q9UKK3|PARP4
1 MVMGIFANCI FCLKVKYLPQ QQKKKLQTDI KENGGKFSFS LNPQCTHIIL DNADVLSQYQ
61 LNSIQKNHVH IANPDFIWKS IREKRLLDVK NYDPYKPLDI TPPPDQKASS SEVKTEGLCP
121 DSATEEEDTV ELTEFGMQNV EIPHLPQDFE VAKYNTLEKV GMEGGQEAVV VELQCSRDSR
181 DCPFLISSHF LLDDGMETRR QFAIKKTSED ASEYFENYIE ELKKQGFLLR EHFTPEATQL
241 ASEQLQALLL EEVMNSSTLS QEVSDLVEMI WAEALGHLEH MLLKPVNRIS LNDVSKAEGI
301 LLLVKAALKN GETAEQLQKM MTEFYRLIPH KGTMPKEVNL GLLAKKADLC QLIRDMVNVC
361 ETNLSKPNPP SLAKYRALRC KIEHVEQNTE EFLRVRKEVL QNHHSKSPVD VLQIFRVGRV
421 NETTEFLSKL GNVRPLLHGS PVQNIVGILC RGLLLPKVVE DRGVQRTDVG NLGSGIYFSD
481 SLSTSIKYSH PGETDGTRLL LICDVALGKC MDLHEKDFSL TEAPPGYDSV HGVSQTASVT
541 TDFEDDEFVV YKTNQVKMKY IIKFSMPGDQ IKDFHPSDHT ELEEYRPEFS NFSKVEDYQL
601 PDAKTSSSTK AGLQDASGNL VPLEDVHIKG RIIDTVAQVI VFQTYTNKSH VPIEAKYIFP
661 LDDKAAVCGF EAFINGKHIV GEIKEKEEAQ QEYLEAVTQG HGAYLMSQDA PDVFTVSVGN
721 LPPKAKVLIK ITYITELSIL GTVGVFFMPA TVAPWQQDKA LNENLQDTVE KICIKEIGTK
781 QSFSLTMSIE MPYVIEFIFS DTHELKQKRT DCKAVISTME GSSLDSSGFS LHIGLSAAYL
841 PRMWVEKHPE KESEACMLVF QPDLDVDLPD LASESEVIIC LDCSSSMEGV TFLQAKQIAL
901 HALSLVGEKQ KVNIIQFGTG YKELFSYPKH ITSNTMAAEF IMSATPTMGN TDFWKTLRYL
961 SLLYPARGSR NILLVSDGHL QDESLTLQLV KRSRPHTRLF ACGIGSTANR HVLRILSQCG
1021 AGVFEYFNAK SKHSWRKQIE DQMTRLCSPS CHSVSVKWQQ LNPDVPEALQ APAQVPSLFL
1081 NDRLLVYGFI PHCTQATLCA LIQEKEFRTM VSTTELQKTT GTMIHKLAAR ALIRDYEDGI
1141 LHENETSHEM KKQTLKSLII KLSKENSLIT QFTSFVAVEK RDENESPFPD IPKVSELIAK
1201 EDVDFLPYMS WQGEPQEAVR NQSLLASSEW PELRLSKRKH RKIPFSKRKM ELSQPEVSED
1261 FEEDGLGVLP AFTSNLERGG VEKLLDLSWT ESCKPTATEP LFKKVSPWET STSSFFPILA
1321 PAVGSYLPPT ARAHSPASLS FASYRQVASF GSAAPPRQFD ASQFSQGPVP GTCADWIPQS
1381 ASCPTGPPQN PPSSPYCGIV FSGSSLSSAQ SAPLQHPGGF TTRPSAGTFP ELDSPQLHFS
1441 LPTDPDPIRG FGSYHPSASS PFHFQPSAAS LTANLRLPMA SALPEALCSQ SRTTPVDLCL
1501 LEESVGSLEG SRCPVFAFQS SDTESDELSE VLQDSCFLQI KCDTKDDSIL CFLEVKEEDE
1561 IVCIQHWQDA VPWTELLSLQ TEDGFWKLTP ELGLILNLNT NGLHSFLKQK GIQSLGVKGR
1621 ECLLDLIATM LVLQFIRTRL EKEGIVFKSL MKMDDASISR NIPWAFEAIK QASEWVRRTE
1681 GQYPSICPRL ELGNDWDSAT KQLLGLQPIS TVSPLHRVLH YSQGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- rectum: 37 nTPM
- small intestine: 37 nTPM
- duodenum: 37 nTPM
- colon: 36 nTPM
- stomach: 33 nTPM
- gallbladder: 28 nTPM
Single-cell type
- neutrophils: 657 nCPM
- neutrophil progenitors: 350 nCPM
- mast cells: 339 nCPM
- foveolar cells: 215 nCPM
- renal collecting duct intercalated cells: 180 nCPM
- proximal tubule cells: 161 nCPM
Immune cell
- basophil: 50 nTPM
- eosinophil: 46 nTPM
- non-classical monocyte: 35 nTPM
- myeloid DC: 28 nTPM
- intermediate monocyte: 26 nTPM
- neutrophil: 24 nTPM
Brain region
- medulla oblongata: 31 nTPM
- white matter: 29 nTPM
- pons: 23 nTPM
- thalamus: 23 nTPM
- choroid plexus: 23 nTPM
- basal ganglia: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage response
- DNA repair
- inflammatory response
- protein modification process
- response to xenobiotic stimulus
Molecular functions
- DNA binding
- enzyme binding
- NAD+ poly-ADP-ribosyltransferase activity
- NAD+-protein mono-ADP-ribosyltransferase activity
- NAD+-protein-aspartate ADP-ribosyltransferase activity
- NAD+-protein-glutamate ADP-ribosyltransferase activity
- nucleotidyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BRCT domain
- von Willebrand factor, type A
- Poly(ADP-ribose) polymerase, regulatory domain
- Poly(ADP-ribose) polymerase, catalytic domain
- VIT domain
- BRCT domain superfamily
- von Willebrand factor A-like domain superfamily
- Poly(ADP-ribose) polymerase, regulatory domain superfamily
- von Willebrand factor type A domain
- BRCA1 C Terminus (BRCT) domain
- Poly(ADP-ribose) polymerase catalytic domain
- Vault protein inter-alpha-trypsin domain
- Protein mono-ADP-ribosyltransferase PARP4
- PARP4, MVP-ID C-terminal domain
- PARP4, WGR-like domain
- PARP4 MVP-ID C-terminal domain
- PARP4 WGR-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARP4 as an antibody target. Whether an autoantibody or antibody against PARP4 could matter depends on whether native PARP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARP4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...